Study of KRAS Neoantigen mRNA Vaccine (ABO2102) in Patients With KRAS -Mutated Solid Tumors

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Study of KRAS Neoantigen mRNA Vaccine (ABO2102) in Patients With KRAS -Mutated Solid Tumors	Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, endocrine system disorder, malignant endocrine neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm	Recruiting	Early phase 1	2025-05-21		NCT06577532

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Ruijin Hospital	454
Suzhou Abogen Biosciences Co., Ltd.	11

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine	Shanghai	China	3

Clinical trials